Latest filing published 07 Aug 2026 for Dianthus Therapeutics, Inc. /DE/, €293k.
All filings by Marino Garcia on record concern Dianthus Therapeutics, Inc. /DE/. Over a trading history stretching from 12 March 2026 to 7 August 2026, the count stands at 17 filings.
On the market, this insider has only sold: 12 sales, €24.2M in total. Other entries cover 5 option exercises.
The newest entry dates from 7 August 2026: an option exercise of €293k, in Dianthus Therapeutics, Inc. /DE/. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations